Screening for insulin resistance in polycystic ovary syndrome: Views of physician members of the american society for reproductive medicine

Albert Asante, Kenan Omurtag, Elizabeth A Stewart, Charles C. Coddington

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

OBJECTIVE: To determine practice patterns for insulin resistance (IR) evaluation and management in women with polycystic ovary syndrome (PCOS) among physician members of the American Society for Reproductive Medicine (ASRM). STUDY DESIGN: Crosssectional survey using a web-based questionnaire. RESULTS: A total of 205 members responded. Respondents were board-certified (94%), or board-eligible (6%), in obstetrics and gynecology. Sixty-four percent of the respondents use the Rotterdam 2003 Criteria for a diagnosis of PCOS. Two-thirds (68%) screen for IR in women with PCOS. Respondents who screen for IR were more likely to also screen for diabetes and impaired glucose tolerance (OR 3.37, 95% CI 1.48–7.21). The 2-hour oral glucose tolerance test with glucose and insulin concentrations was the most common IR screening test used (45%). Metformin therapy was used by 33% of respondents for “all women with PCOS who have IR.” The majority (68%) responded that there is a need for a committee opinion from ASRM on IR testing in PCOS. CONCLUSION: Two-thirds of ASRM physician members surveyed screen women with PCOS for IR in spite of the lack of general consensus on the need for such screening from endocrine societies.

Original languageEnglish (US)
Pages (from-to)371-377
Number of pages7
JournalThe Journal of reproductive medicine
Volume60
Issue number5
StatePublished - Oct 1 2015

Fingerprint

Reproductive Medicine
Polycystic Ovary Syndrome
Insulin Resistance
Physicians
Glucose Intolerance
Metformin
Glucose Tolerance Test
Gynecology
Obstetrics
Surveys and Questionnaires
Insulin
Glucose

Keywords

  • Blood glucose
  • Diabetes mellitus
  • Glucose intolerance
  • Glucose tolerance test
  • Insulin resistance
  • Insulin sensitivity
  • Metformin
  • Polycystic ovary syndrome

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Screening for insulin resistance in polycystic ovary syndrome : Views of physician members of the american society for reproductive medicine. / Asante, Albert; Omurtag, Kenan; Stewart, Elizabeth A; Coddington, Charles C.

In: The Journal of reproductive medicine, Vol. 60, No. 5, 01.10.2015, p. 371-377.

Research output: Contribution to journalArticle

@article{b749caa7415941d9be2ebfbff191a5dd,
title = "Screening for insulin resistance in polycystic ovary syndrome: Views of physician members of the american society for reproductive medicine",
abstract = "OBJECTIVE: To determine practice patterns for insulin resistance (IR) evaluation and management in women with polycystic ovary syndrome (PCOS) among physician members of the American Society for Reproductive Medicine (ASRM). STUDY DESIGN: Crosssectional survey using a web-based questionnaire. RESULTS: A total of 205 members responded. Respondents were board-certified (94{\%}), or board-eligible (6{\%}), in obstetrics and gynecology. Sixty-four percent of the respondents use the Rotterdam 2003 Criteria for a diagnosis of PCOS. Two-thirds (68{\%}) screen for IR in women with PCOS. Respondents who screen for IR were more likely to also screen for diabetes and impaired glucose tolerance (OR 3.37, 95{\%} CI 1.48–7.21). The 2-hour oral glucose tolerance test with glucose and insulin concentrations was the most common IR screening test used (45{\%}). Metformin therapy was used by 33{\%} of respondents for “all women with PCOS who have IR.” The majority (68{\%}) responded that there is a need for a committee opinion from ASRM on IR testing in PCOS. CONCLUSION: Two-thirds of ASRM physician members surveyed screen women with PCOS for IR in spite of the lack of general consensus on the need for such screening from endocrine societies.",
keywords = "Blood glucose, Diabetes mellitus, Glucose intolerance, Glucose tolerance test, Insulin resistance, Insulin sensitivity, Metformin, Polycystic ovary syndrome",
author = "Albert Asante and Kenan Omurtag and Stewart, {Elizabeth A} and Coddington, {Charles C.}",
year = "2015",
month = "10",
day = "1",
language = "English (US)",
volume = "60",
pages = "371--377",
journal = "The Journal of reproductive medicine",
issn = "0024-7758",
publisher = "Donna Kessel",
number = "5",

}

TY - JOUR

T1 - Screening for insulin resistance in polycystic ovary syndrome

T2 - Views of physician members of the american society for reproductive medicine

AU - Asante, Albert

AU - Omurtag, Kenan

AU - Stewart, Elizabeth A

AU - Coddington, Charles C.

PY - 2015/10/1

Y1 - 2015/10/1

N2 - OBJECTIVE: To determine practice patterns for insulin resistance (IR) evaluation and management in women with polycystic ovary syndrome (PCOS) among physician members of the American Society for Reproductive Medicine (ASRM). STUDY DESIGN: Crosssectional survey using a web-based questionnaire. RESULTS: A total of 205 members responded. Respondents were board-certified (94%), or board-eligible (6%), in obstetrics and gynecology. Sixty-four percent of the respondents use the Rotterdam 2003 Criteria for a diagnosis of PCOS. Two-thirds (68%) screen for IR in women with PCOS. Respondents who screen for IR were more likely to also screen for diabetes and impaired glucose tolerance (OR 3.37, 95% CI 1.48–7.21). The 2-hour oral glucose tolerance test with glucose and insulin concentrations was the most common IR screening test used (45%). Metformin therapy was used by 33% of respondents for “all women with PCOS who have IR.” The majority (68%) responded that there is a need for a committee opinion from ASRM on IR testing in PCOS. CONCLUSION: Two-thirds of ASRM physician members surveyed screen women with PCOS for IR in spite of the lack of general consensus on the need for such screening from endocrine societies.

AB - OBJECTIVE: To determine practice patterns for insulin resistance (IR) evaluation and management in women with polycystic ovary syndrome (PCOS) among physician members of the American Society for Reproductive Medicine (ASRM). STUDY DESIGN: Crosssectional survey using a web-based questionnaire. RESULTS: A total of 205 members responded. Respondents were board-certified (94%), or board-eligible (6%), in obstetrics and gynecology. Sixty-four percent of the respondents use the Rotterdam 2003 Criteria for a diagnosis of PCOS. Two-thirds (68%) screen for IR in women with PCOS. Respondents who screen for IR were more likely to also screen for diabetes and impaired glucose tolerance (OR 3.37, 95% CI 1.48–7.21). The 2-hour oral glucose tolerance test with glucose and insulin concentrations was the most common IR screening test used (45%). Metformin therapy was used by 33% of respondents for “all women with PCOS who have IR.” The majority (68%) responded that there is a need for a committee opinion from ASRM on IR testing in PCOS. CONCLUSION: Two-thirds of ASRM physician members surveyed screen women with PCOS for IR in spite of the lack of general consensus on the need for such screening from endocrine societies.

KW - Blood glucose

KW - Diabetes mellitus

KW - Glucose intolerance

KW - Glucose tolerance test

KW - Insulin resistance

KW - Insulin sensitivity

KW - Metformin

KW - Polycystic ovary syndrome

UR - http://www.scopus.com/inward/record.url?scp=84949782606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949782606&partnerID=8YFLogxK

M3 - Article

C2 - 26592060

AN - SCOPUS:84949782606

VL - 60

SP - 371

EP - 377

JO - The Journal of reproductive medicine

JF - The Journal of reproductive medicine

SN - 0024-7758

IS - 5

ER -